Why GN Store Nord stock moves
GN Store Nord surged on that day's Q3 report, rising very sharply.
Written after the close on ·
Updated 08:52 with news that came after the close
Why today
15,876 news analyzed todayGN Store Nord surged on that day's Q3 report, rising very sharply.
OMX Copenhagen 25 fell slightly, so the stock clearly moved against the market.
Tariff refunds drove much of the profit beat, and the company kept its 2026 guidance.
It also confirmed plans to pay shareholders at least DKK 4 billion through 2027.
Trading volume was far above normal, and the move was one of the largest in the past year.
Today's move of +11.61% was 9.6 times a normal day's 1.2%. OMX Copenhagen 25 moved −0.23% on the same day.
GN Store Nord +11.61%OMX Copenhagen 25 −0.23%Much stronger than the market
What analysts expect, and how often they have been right
Analysts’ estimates for GN Store Nord.
GN Store Nord earned more than expected in 2 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 6 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 123.65 DKK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedDKK
Next reported quarter: expected earnings per share of 1.11 DKK (February 11). For the current fiscal year, expected earnings per share changed from 1.54 DKK three months ago to 1.93 DKK now. 2026 estimate: 1.93 DKK. 2027 estimate: 4.50 DKK. One analyst made the estimate for the quarter.
Has the share price followed the business?
Price and earnings moved in the same direction: 1 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −20% and earnings per share −34%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn DKK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn DKK
Price and earnings moved in the same direction: 1 out of 3 years.Market cap (Now): 18.0 bn DKKRevenue 2025: 16.8 bn DKK
What the key figures say about GN Store Nord
The figures connect what GN Store Nord earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 1.64 DKK–6.78 DKK. Peers: Elekta -0.95 SEK, Ambu 2.42 DKK, Embla Medical 1.42 DKK. 2026 estimate: 1.93 DKK (-0.18 DKK–4.99 DKK). 2027 estimate: 4.50 DKK (1.80 DKK–7.42 DKK).
What the company sold during the year.
2022–2025: 16.8 bn DKK–18.7 bn DKK. Peers: Elekta 16.6 bn SEK, Ambu 6.2 bn DKK, Embla Medical $997M. 2026 estimate: 9.5 bn DKK (9.4 bn DKK–9.6 bn DKK). 2027 estimate: 10.0 bn DKK (9.6 bn DKK–10.2 bn DKK).
The percentage of revenue left after the costs of running the business.
2022–2025: 5.2%–9.9%. Peers: Elekta 1.7%, Embla Medical 13.6%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 2.4%–9.1%. Peers: Elekta −4.3%, Ambu 8.4%, Embla Medical 10.4%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 19.7–104.8. Peers: Ambu 36.2, Embla Medical 19.7. 2026 estimate: 64.1. 2027 estimate: 27.5.
What investors pay for each unit the company sells.
2022–2025: 0.93–1.38. Peers: Elekta 1.40, Ambu 3.66. 2026 estimate: 1.89. 2027 estimate: 1.81.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 0.00 DKK–1.55 DKK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 0.0%–1.0%. Peers: Elekta 4.0%, Ambu 0.5%, Embla Medical 0.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 3.37–6.24. Peers: Elekta 2.45, Ambu -0.14, Embla Medical 2.62.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.43–3.01. Peers: Elekta 3.19, Ambu 3.76.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 17.2–54.3.
Cash left after investments, divided by the number of shares.
2022–2025: -8.13 DKK–9.07 DKK. Peers: Elekta 4.04 SEK, Embla Medical $0.25.
The percentage of assets financed by shareholders’ equity.
2022–2025: 22.2%–37.3%.
What to watch next, and why
The earnings report shows how GN Store Nord's revenue and profit have changed.
- Earnings report
The earnings report shows how GN Store Nord's revenue and profit have changed.
Add to calendar
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days GN Store Nord usually moved about 9.4%. On a normal day it moves 1.2%.
+11.61% Why? −10.47% −6.73% −12.78%
10,000 DKK in GN Store Nord bought on November 7, 2016 is worth 9,290 DKK today, with dividends reinvested.
The same amount in OMX Copenhagen with dividends would have become 25,800 DKK.
What would 10,000 DKK in GN Store Nord be worth today? →
What would 10,000 DKK in GN Store Nord be worth today?
9,290 DKK
with dividends reinvested, bought on November 7, 2016. The same amount in OMX Copenhagen with dividends would have become 25,800 DKK.
At worst it was worth 6,180 DKK (April 9, 2025).
The five biggest days of the journey
· +21.2% · the whole market rose 1.2% the same day
· +19.9% · the whole market rose 0.1% the same day · report day
· +13.0% · the whole market fell 0.2% the same day · report day
· −12.8% · the whole market rose 0.8% the same day · report day
· −12.8% · the whole market fell 2.6% the same day · report day
Earlier days
+15.83% market +1.75% GN Store Nord rose very sharply over the week, far more than the OMX Copenhagen 25 index, which rose clearly. Read →
GN Store Nord rose very sharply over the week, far more than the OMX Copenhagen 25 index, which rose clearly.
The main driver was its third-quarter report on 5 November, which beat expectations, helped by one-off tariff refunds that boosted profit.
Analysts then raised their price targets, the fair share prices they see, on 6 November, which likely added momentum.
Its share price was also near its one-year high, so the move was very big for the stock.
+3.83% market +1.87% GN Store Nord rose without a company-news explanation. Read →
GN Store Nord rose without a company-news explanation.
OMX Copenhagen 25 also rose sharply over the same days, so the market was strong too.
The stock fell slightly over the last five trading days, moving against the market's rise.
Trading volume was about twice a normal session, showing heavy interest in the shares.
The next earnings report, the company's quarterly results, is due Thursday 5 November 2026.
+0.71% market +0.22% GN Store Nord rose; the day was ordinary for the stock. Read →
GN Store Nord rose; the day was ordinary for the stock.
The stock moved in line with OMX Copenhagen 25, which also rose slightly.
Over the last five trading days, the shares fell sharply while the Danish market rose sharply, a large move against the market.
Earlier, DNB Carnegie raised its price target, the share price it sees as fair, and Jyske Bank cut its rating to hold.
−3.13% market +0.07% GN Store Nord fell sharply without company news. Read →
GN Store Nord fell sharply without company news.
The market was roughly flat, so the drop was stock-specific.
Over the last five trading days it fell clearly, moving against a market that rose very sharply.
Trading volume was about twice a normal session.
Earnings are due Thursday 5 November 2026, which is likely why traders are repositioning now.
−4.77% market +4.94% GN Store Nord fell clearly over the week, moving against a sharply rising Danish market. Read →
GN Store Nord fell clearly over the week, moving against a sharply rising Danish market.
Trading was heavier than usual, about twice a normal session, as the stock slid.
Jyske Bank cut its rating to hold, meaning neutral, and set a lower fair value of 110 kroner, which likely weighed on the shares.
DNB Carnegie raised its price target to 122 kroner, but that did not stop the decline.
−2.26% market +0.30% GN Store Nord fell, against a slightly rising market. Read →
GN Store Nord fell, against a slightly rising market.
DNB Carnegie raised its price target, the share price it sees as fair, to DKK 122 and kept its buy rating.
The stock still rose slightly over the last five trading days, less than OMX Copenhagen 25.
Trading was about twice its normal level, and the next earnings report is on Thursday 5 November 2026.
+2.77% market +0.57% GN Store Nord rose without a company-news explanation. Read →
GN Store Nord rose without a company-news explanation.
Compared with the market, it climbed more than OMX Copenhagen 25, which rose only slightly over the same day.
Over the last five trading days the shares rose sharply, a big move for the stock, roughly twice a normal five-day stretch.
Trading volume was about twice a normal session, so heavy buying likely accompanied the rise.
The next earnings report, a quarterly results release, is due Thursday 5 November 2026.
Learn more · Why do stocks go up and down?